1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine
C23H25N5O2S — CID 118681856
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine
1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine (PubChem CID 118681856) has the molecular formula C23H25N5O2S and a molecular weight of 435.55 g/mol. Its IUPAC name is 1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine.
Molecular Properties
| Compound Name | 1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine |
|---|---|
| PubChem CID | 118681856 |
| Molecular Formula | C23H25N5O2S |
| Molecular Weight | 435.55 g/mol |
| Exact Mass | 435.17 |
| IUPAC Name | 1-[[(5S)-5-methyl-1-(3-methylphenyl)sulfonylpyrrolidin-3-yl]methyl]-5-(1H-pyrazol-4-yl)pyrrolo[3,2-b]pyridine |
| SMILES | Cc1cccc(S(=O)(=O)N2CC(Cn3ccc4nc(-c5cn[nH]c5)ccc43)C[C@@H]2C)c1 |
| InChI | InChI=1S/C23H25N5O2S/c1-16-4-3-5-20(10-16)31(29,30)28-15-18(11-17(28)2)14-27-9-8-22-23(27)7-6-21(26-22)19-12-24-25-13-19/h3-10,12-13,17-18H,11,14-15H2,1-2H3,(H,24,25)/t17-,18?/m0/s1 |
| InChIKey | JELGCHFZXLOUKL-ZENAZSQFSA-N |
| XLogP | 3.83 |
| TPSA | 83.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.55 |
| LogP ≤ 5 | 3.83 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118681856 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.